Open Access
Instituto superior de ci ncias da sa⁄de
Egas Moniz
- 01 Jan 2014
TL;DR: The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding.
read more
Abstract: 5 Abstract Feeding behavior depends on the balance between food intake and energy expenditure. This regulation occurs in the brain where the hypothalamus plays a key role. The hypothalamus receives adiposity signals by insulin and leptin that gives information about the state of energy reserves. When their levels are low, hypothalamus nuclei send signals through the orexigenic neuropeptides NPY, AgRP, CRH and orexins and ghrelin, a peripheral peptide that stimulate food intake. During ingestion, the first signals received by the brain are the pleasure channeled through the reward system, and the distension of the stomach that is communicated to the brainstem via the vagus nerve. Digestion causes the release of hormones that act as peripheral satiety signals, operating in the brainstem or in the arcuate nucleus (ARC) of the hypothalamus. Examples of such hormones are amylin, pancreatic polypeptide (PP), oxyntomodulin (OXM), cholecystokinin (CCK), glucagon-related peptide (GLP1) and peptide YY (PYY). The regulation of feeding behavior also involves the monoamines dopamine, noradrenalin and serotonin involved in the reward center, a system that values the intake by the feeling of pleasure, and the endocannabinoid system that protects from anxiety and stimulates feeding. Actually, there are few alternative drugs to treat obesity that are effective and safe because the pathways involved in feeding behavior are often easily compensated by other pathways, and are involved in the regulation of other systems.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Journal Article
BRIEF COMMUNICATION ARISING: Gut hormone PYY3-36 physiologically inhibits food intake
Rachel L. Batterham,Michael A. Cowley,Caroline J. Small,Herbert Herzog,Mark A Cohen,C. L. Dakin,Alison M. Wren,Audrey E. Brynes,Malcolm J. Low +8 more
TL;DR: The authors showed that post-prandial elevation of PYY3-36 may act through the arcuate nucleus Y2R to inhibit feeding in a gut-hypothalamic pathway.
1.9K
•Journal Article
MDS Clinical Diagnostic Criteria for Parkinson's Disease (S19.001)
Ronald B. Postuma,Daniela Berg +1 more
TL;DR: The International Parkinson and Movement Disorder Society (MDS) Clinical Diagnostic Criteria for Parkinson9s disease as discussed by the authors have been proposed for clinical diagnosis, which are intended for use in clinical research, but may also be used to guide clinical diagnosis.
1.6K
•Journal Article
Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting
Csaba Fekete,Emese Mihály,Lu Guang Luo,Joseph Kelly,Jes Thorn Clausen,Quan Fu Mao,William M. Rand,Larry G. Moss,Michael J. Kuhar,Charles H. Emerson,Ivor M. D. Jackson,Ronald M. Lechan +11 more
TL;DR: In this paper, triple-labeling fluorescent in situ hybridization and immunofluorescence were performed to reveal the morphological relationships between pro-TRH mRNA-containing neurons and CART- and alpha-MSH-immunoreactive (IR) axons.
151
Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects
Erik Näslund,Neil A. King,S. Mansten,N. Adner,Jens J. Holst,M. K. Gutniak,Per M. Hellström +6 more
- 01 Jan 2004
TL;DR: In this article, a 5-day infusion of recombinant glucagon-like peptide-1 (7-36)amide (rGLP-1) was shown to cause significant weight loss in type 2 diabetics when administered for 6 weeks as a continuous subcutaneous infusion.
149
References
Differential roles for cholecystokinin a receptors in energy balance in rats and mice.
TL;DR: Although CCK-AR plays a role in the mediation of CCK actions in the control of meal size in both rats and mice, CCK -AR seems to contribute to modulating DMH NPY levels only in rats.
Evaluation of a conventional glass ionomer cement with new zinc formulation: effect of coating, aging and storage agents
Julius Zoergiebel,Nicoleta Ilie +1 more
TL;DR: The new development (ChemFil Rock) might represent a promising approach regarding longevity of GIC fillings in molar regions, due to the high flexural strength and the absence of visible surface defects like crazing and voids.
120
Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis.
TL;DR: The PRP was effective in the treatment of PEDs and could be an effective, novel treatment option for chronic ocular surface disease due to its high concentration of platelet-contained growth factors, most notably EGF.
120
Ketamine enantiomers in the rapid and sustained antidepressant effects.
TL;DR: The mechanism of action, drug efficacy, and the side effects ofketamine are explained; the antidepressive effects of ketamine; the individual effects of Ketamine isomers, R(–) ketamine and S(+) ketamines; the effects of the combination of ketamines with electroconvulsive therapy; and the possible use of ketamate in treating depression are explained.
119
Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature.
TL;DR: Remineralization of white spot lesions has been achieved clinically by applying pastes based on CPP-ACP compounds, and a similar effect to self-applied fluorides has been observed in reducing the appearance of new caries lesions in patients with xerostomia.